NAVB - Navidea Biopharmaceuticals, Inc.

NYSE American - NYSE American Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5
Enterprise Value 3
Trailing P/E
Forward P/E 1
PEG Ratio (5 yr expected) 1
Price/Sales (ttm)
Price/Book (mrq)
Enterprise Value/Revenue 3
Enterprise Value/EBITDA 6

Trading Information

Stock Price History

Beta (5Y Monthly) 0.90
52-Week Change 3-39.17%
S&P500 52-Week Change 325.98%
52 Week High 34.2000
52 Week Low 30.4900
50-Day Moving Average 31.1994
200-Day Moving Average 30.8036

Share Statistics

Avg Vol (3 month) 3628.28k
Avg Vol (10 day) 3133.51k
Shares Outstanding 518.08M
Float 11.09M
% Held by Insiders 142.42%
% Held by Institutions 13.20%
Shares Short (Dec 30, 2019) 4715.32k
Short Ratio (Dec 30, 2019) 43.68
Short % of Float (Dec 30, 2019) 48.02%
Short % of Shares Outstanding (Dec 30, 2019) 43.96%
Shares Short (prior month Nov 28, 2019) 4713.34k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:20
Last Split Date 3Apr 25, 2019

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2018
Most Recent Quarter (mrq)Sep 29, 2019


Profit Margin 0.00%
Operating Margin (ttm)-1,412.49%

Management Effectiveness

Return on Assets (ttm)-83.38%
Return on Equity (ttm)-1,182.64%

Income Statement

Revenue (ttm)657.85k
Revenue Per Share (ttm)0.05
Quarterly Revenue Growth (yoy)2.30%
Gross Profit (ttm)1.07M
Net Income Avi to Common (ttm)-11.34M
Diluted EPS (ttm)-0.9300
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)2.84M
Total Cash Per Share (mrq)0.16
Total Debt (mrq)824.68k
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.90
Book Value Per Share (mrq)-0.04

Cash Flow Statement

Operating Cash Flow (ttm)-8.75M
Levered Free Cash Flow (ttm)-5.19M